Melatonine Dmb

Melatonin, the active ingredient in Melatonine Dmb, is a melatonin receptor agonist presented as an oral formulation for oral use. It acts on MT1 and MT2 receptors to support the regulation of the circadian rhythm and facilitate sleep onset in adults who have difficulty falling or staying asleep, including those with shift‑work related disturbances.

GNH USA supplies Melatonine Dmb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonine Dmb is a melatonin receptor agonist used to address disorders of the sleep‑wake cycle.

- Insomnia: helps reduce time to fall asleep and may improve sleep continuity. - Sleep‑wake rhythm disorders: assists in aligning the internal clock with the desired sleep schedule.

Melatonine Dmb is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain often occurring after the first dose. - Dizziness: transient light‑headedness, especially when rising quickly. - Nausea: occasional stomach upset that resolves without intervention. - Daytime sleepiness: residual drowsiness if taken too late in the evening.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe dizziness or vertigo: may indicate an underlying neurological response. - Mood changes: depression or agitation that persists. - Abnormal heart rhythm: palpitations or arrhythmia requiring medical assessment. - Hallucinations or vivid dreams: rare neuropsychiatric events.

When considering Melatonine Dmb, several safety measures should be observed.

- Assess medical history: evaluate existing sleep disorders, depression, or seizure conditions. - Avoid alcohol: concurrent use may enhance sedative effects. - Monitor elderly patients: increased sensitivity to drowsiness and falls. - Do not operate machinery: risk of impaired alertness after dosing. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Melatonine Dmb may interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Benzodiazepines: additive central nervous system depression. - Antidepressants (SSRIs, MAOIs): potential alteration of melatonin metabolism. - Anticoagulants: possible effect on platelet aggregation.

Moderate Interactions (Monitor Closely): - Caffeine: may counteract the sleep‑promoting effect. - Beta‑blockers: can increase endogenous melatonin levels. - Oral contraceptives: may raise melatonin concentrations, requiring observation.